Page last updated: 2024-08-17
carbachol and plerixafor
carbachol has been researched along with plerixafor in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Allaway, GP; De Clercq, E; Donzella, GA; Esté, JA; Henson, G; Lin, SW; Maddon, PJ; Moore, JP; Nagashima, KA; Sakmar, TP; Schols, D | 1 |
Other Studies
1 other study(ies) available for carbachol and plerixafor
Article | Year |
---|---|
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; Calcium; Carbachol; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Fusion; Cell Line; Cells, Cultured; Chemokine CCL5; Chemokine CXCL12; Chemokines, CXC; Cyclams; Cytokines; Heterocyclic Compounds; HIV Envelope Protein gp120; HIV-1; Humans; Interleukin-2; Kinetics; Membrane Fusion; Receptors, CCR5; Receptors, CXCR4; Signal Transduction; Somatostatin | 1998 |